Here are relevant reports on : teleradiology-market
-
Corrosion Inhibitors Market by Compound(Organic, Inorganic), Type(Water Based, Oil Based and VCI), Application, End-Use (Power Generation, Oil & Gas, Metal & Mining, Pulp & Paper, Utilities, Chemical), and Region - Global Forecast to 2026
The Corrosion Inhibitors Market is expected to grow from USD 7.9 billion in 2021 to USD 10.1 billion by 2026, at a CAGR of 4.9% during the forecast period. Major players operating in the global corrosion inhibitor market include Solenis (US), Nouryon (The Netherlands), Baker Hughes Company (US), Ecolab (US), BASF SE (Germany), SUEZ Water Technologies & Solutions (France), DOW Chemical Company (US), Lubrizol Corporation (US), Lanxess (Germany), and Henkel Corporation (Germany).
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
Global Weight Loss Drugs, Supplements And Cosmetics Market
Individuals with high BMI have a greater risk of developing diseases such as cancer and diabetes. This holds true for both men and women; and those with BMI above 35 are at the highest risk. However, increasing awareness about obesity is encouraging consumers to seek medical assistance and consultation for weight reduction. The market for weight-loss drugs, cosmetics, and supplements is witnessing a significant growth as these do not involve strict diet or exercise regimens. Top pharmaceutical companies have thus increased R&D investments for anti-obesity drugs with minimal or no side effects.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Advanced Phase Change Material (PCM) Market: Global Forecast (2010 – 2015)
The increasing demand for energy-saving and environment-friendly technology is driving the growth of the global phase change material (PCM) market. The global PCM market is expected to grow from $300.8 million in 2009 to $1,488.1 million in 2015, at an estimated CAGR of 31.7% from 2010 to 2015. The paraffin-based PCM market commands the largest share of the overall PCM market in terms of value, while salt hydrate-based PCMs lead the market in terms of volume.
- Published: July 2010
- Price: $ 4950
- TOC Available:
-
Metals Cans Market by Fabrication type (2 Piece Cans, 3 Piece Cans), Application (Food and Beverage), Coating Type, Material Type, Beverage Can Capacity, Degree of Internal Pressure, and Region - Global Forecast to 2029
The Food and Beverage Metal Cans Market is projected to reach USD 70.72 billion by 2029, at a CAGR of 7.0% during the forecast period. Key players operating in the food and beverage metal cans market include Crown Holdings, Inc (US), Ball Corporation (US), Silgan Holdings Inc. (US), Ardagh Group (Luxembourg), CCL Industries (US), CAN-PACK S.A (Poland), Kian-Joo Group (Malaysia), CPMC Holdings (China), Envases Group (Spain), and Toyo Seikan Group Holdings, Ltd. (Japan). These players in this market are focusing on increasing their presence through expansion and collaboration. These companies have a strong presence in North America, Asia Pacific, and Europe.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Healthcare IT Market by Solution [Clinical (EHR, PHM, PACs & VNA, Telehealth, RCM, CDSS, LIS), Nonclinical (Analytics, RCM, Pharmacy, Interoperability), Service (Claim, Billing, Supply)], End User (Hospital, ASC, Pharmacy, Payer) - Global Forecast to 2030
The global healthcare IT market, valued at US$420.23 billion in 2024, stood at US$480.49 billion in 2025 and is projected to advance at a resilient CAGR of 14.9% from 2025 to 2030, culminating in a forecasted valuation of US$961.26 billion by the end of the period. driven by rapid digital transformation across hospitals, increasing adoption of cloud-based solutions, and greater integration of AI to improve clinical and the efficiency of operations.
- Published: January 2026
- Price: $ 8150
- TOC Available:
-
Hospital EMR Systems Market by Component (Software, Services, Hardware), Delivery Mode (Cloud, On-premise), Type (Specialty EMR), Hospital Size (Small, Large Hospitals) and Region (North America, Europe, Asia Pacific) - Global Forecasts to 2025
The global hospital EMR systems market growth is primed to transition from USD 14.2 billion in 2020 to USD 20.7 billion by 2025, showcasing a strong CAGR of 7.8%. This growth is driven by increasing hospital adoption of EMR solutions, the need to reduce healthcare costs, government mandates, and the rise in patient volume due to the COVID-19 pandemic.
- Published: June 2020
- Price: $ 4950
- TOC Available:
-
Global Pediatric Healthcare Market (2012 - 2017)
Children often suffer from short term diseases related to respiratory or ocular infections. Apart from these, gastrointestinal infections accompanied by diarrhea and injury related disorders are common in children. Many times these are just short term diseases and treated on daily basis by pediatricians but treatment of these diseases consume large amount of time and financial resources of their parents and caregivers involved in primary care. Change in lifestyle has been a major factor for increased prevalence of such diseases.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Mobile Payment Technology (Near Field Communication) - Remote and Proximity M-payments Market Forecast (2010 - 2015)
The market for NFC (Near Field Communication) mobile payments in the U.S. is in the nascent stage with an adoption rate of only 1.7%; this represents a huge opportunity for early movers offering the same. Adopting NFC mobile payment will open new revenue channels for banks as well as mobile operators as more than 94% of the U.S. population owns a mobile phone, and 60% of these have a card slot in their mobile phone. With the help of NFC technology, banks will be able to tap micro transactions made by cash, representing around 20% of the total transactions in the U.S. This will also help banks to capture the growing GEN Y population as well as the huge underbanked and unbanked population.
- Published: August 2010
- Price: $ 4950
- TOC Available:
-
Monoclonal Antibodies Market (2012 - 2017)
The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008. Monoclonal antibodies present significant opportunities as they are targeted therapy (They impact only the diseased cells and do not harm healthy cells) unlike chemotherapy drugs.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Active Pharmaceutical Ingredients (API) Market by type (Innovative, Generic), Synthesis (synthetic, biotech), Potency (HPAPI), Product (mAbs, hormones), Drug (OTC, Rx), Application (Diabetes, Oncology), Competitive landscape - Global forecast to 2030
The global active pharmaceutical ingredient market, valued at US$136.22 billion in 2024, stood at US$144.20 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2024 to 2030, culminating in a forecasted valuation of US$198.39 billion by the end of the period. The growth of the active pharmaceutical ingredients market is driven by the surge in demand for complex APIs, such as high-potency API, peptides, oligonucleotides, and increasing government incentives and supply chain reshoring.
- Published: October 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
